摘要 |
<p>The use of aerosolized particles of mometasone furoate for the preparation of medicaments in the form of dry powders, solutions, or aqueous suspension for once-a-day treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.</p> |